Transposon Therapeutics
PrivateLast Round
Grant
Mar 4, 2026
Total Funding Raised
$54.12M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Transposon Therapeutics is a biotechnology company developing a platform of novel nucleoside reverse transcriptase inhibitors for the treatment of neurodegenerative and aging-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Transposon Therapeutics Comparables
Compare Transposon Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Asceneuron | 78% | |
| Vesper Bio ApS | 71% | |
| Coya Therapeutics, Inc. | 70% | |
Transposon Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 4, 2026 | ||||
| Grant | Jul 9, 2025 | ||||
| Debt | Jul 15, 2024 | ||||
| VC Round | Jan 12, 2023 | ||||
| Series A | Dec 9, 2020 | ||||
Seed | May 6, 2020 |
Key People
Founding team and executive leadership
Transposon Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Domain Associates | Seed, Series A, VC Round |
| Canaan Partners | Seed, Series A, VC Round |
| Catalys Pacific | Series A |
| ARPA-H | Grant |
| Lumira Ventures | Series A |
| Alzheimer's Drug Discovery Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2026
$22M grant round closed.
Transposon Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Transposon Therapeutics's valuation, stock price, and market status.